Novonix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	8.05	6.1	3.89	2.85	1.32
Revenue Growth (YoY)	32.02%	56.69%	36.57%	116.42%	-
Cost of Revenue	2.82	1.72	0.81	0.83	0.54
Gross Profit	5.24	4.38	3.08	2.02	0.78
Selling, General & Admin	39.2	29.55	7.2	4.57	3.87
Research & Development	5.75	5.1	2.09	1.62	0
Other Operating Expenses	10.36	18.75	7.74	5.99	16.74
Operating Expenses	55.32	53.4	17.03	12.19	20.61
Operating Income	-50.08	-49.03	-13.94	-10.17	-19.83
Interest Expense / Income	2.86	1.51	0.17	3.57	1.13
Other Expense / Income	-6.5	1.32	-0.67	-0.31	-1.74
Pretax Income	-46.45	-51.86	-13.45	-13.43	-19.22
Income Tax	-0.2	0	0	0	-0.28
Net Income	-46.25	-51.86	-13.45	-13.43	-18.94
Shares Outstanding (Basic)	487	464	366	136	-
Shares Outstanding (Diluted)	487	464	366	136	-
Shares Change	4.96%	26.80%	169.49%	-	-
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.61
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.61
Free Cash Flow	-55.42	-112.99	-25.66	-7.43	-4.46
Free Cash Flow Per Share	-0.46	-0.97	-0.28	-0.22	-
Gross Margin	65.02%	71.73%	79.18%	70.73%	59.20%
Operating Margin	-621.75%	-803.55%	-358.12%	-356.75%	-1505.04%
Profit Margin	-574.19%	-850.01%	-345.34%	-471.06%	-1437.60%
Free Cash Flow Margin	-688.11%	-1851.97%	-659.13%	-260.47%	-338.92%
EBITDA	-43.58	-50.35	-13.28	-9.86	-18.08
EBITDA Margin	-541.11%	-825.22%	-340.95%	-345.73%	-1372.58%
EBIT	-43.58	-50.35	-13.28	-9.86	-18.08
EBIT Margin	-541.11%	-825.22%	-340.95%	-345.73%	-1372.58%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).